Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Windlas Biotech Ltd. ( (IN:WINDLAS) ) has shared an update.
Windlas Biotech Ltd. has announced a scheduled meeting with analysts and institutional investors at their Dehradun facility on April 11, 2025. The meeting will focus on publicly available information, ensuring no unpublished price-sensitive information is discussed, which reflects the company’s commitment to transparency and compliance with SEBI regulations.
More about Windlas Biotech Ltd.
Windlas Biotech Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of generic pharmaceutical products. The company is known for its expertise in producing a wide range of formulations, catering to both domestic and international markets.
YTD Price Performance: -10.38%
Average Trading Volume: 6,567
Current Market Cap: 19.68B INR
For detailed information about WINDLAS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue